Fact CheckerSign in

NCT06256159Completed

Validity and Reliability of the 12-item Multiple Sclerosis Walking Scale (12-WS) in Subjects With Spinal Cord Injury

Source: ClinicalTrials.gov · Last updated 29 May 2025

Brief summary (registry, in English)

Established gait assessments for subjects with spinal cord injury (SCI) (6MWT, 10MWT, TUG, SCIM III and WISCI II) are widely used in the clinical and research setting. So far, no valid measurement exists that assesses the patients' perspective of walking ability in SCI. As there is the 12-item Multiple Sclerosis Walking Scale (12-WS) to assess the patients' perspective on gait ability in patients with multiple sclerosis, it is hypothesized that the 12-WS would also be a valid instrument for subjects with incomplete SCI. The main goal of this study is to collect data from clinical gait assessments in subjects with spinal lesions and to demonstrate that the 12-WS is a valid and reliable patient-reported outcome measurement for individuals with incomplete spinal cord injury.

Status (registry)
Completed
Study type
Interventional
Enrollment
67 (actual)
First submitted
19 Jan 2024
Start date
22 Mar 2024
Primary completion date
5 Mar 2025
Lead sponsor
University of Zurich
NCT number
NCT06256159

What you commit to

  • Study type: Interventional
  • Participants enrolled: 67
  • From 22 Mar 2024 to the primary completion date, 5 Mar 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
  • History of major pulmonary condition (e.g., chronic obstructive pulmonary disease GOLD II-IV

Other

  • Women who are pregnant or breast feeding
  • Current orthopaedic problems of lower limbs
  • Current major depression or psychosis
  • Participation in another interventional study (except specTra-study) that may have an impact on walking function.

Who the study is looking for

  • Age 18-80 years
  • Diagnosis of chronic spinal cord injury (\>6 months; cervical or thoracic motor incomplete traumatic or non-traumatic (AIS C, D) above T12
  • Must have impaired walking function as demonstrated by neurological examination.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Swiss Paraplegic Center
Coordinator of this site? Confirm its status
NottwilSwitzerlandUnknown status
Balgrist University Hospital
Coordinator of this site? Confirm its status
ZurichSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.